Nancy Simonian
Chief Executive Officer presso SYROS PHARMACEUTICALS, INC.
Patrimonio netto: 704 370 $ in data 31/03/2024
Provenienza dei contatti di primo grado di Nancy Simonian
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Princeton University
256
| College/University | Other Consumer Services | 256 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.
242
| Non-Profit Organization | Miscellaneous Commercial Services | 242 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.
105
| Subsidiary | Pharmaceuticals: Major | 105 |
52
| Public Company | Pharmaceuticals: Major | 52 |
51
| Subsidiary | Pharmaceuticals: Major | 51 |
42
| Public Company | Pharmaceuticals: Major | 42 |
Public Company | Biotechnology | 39 | |
The Damon Runyon Cancer Research Foundation
The Damon Runyon Cancer Research Foundation Miscellaneous Commercial ServicesCommercial Services The Damon Runyon Cancer Research Foundation supports cancer research through grants to scientists in fields including cellular biology, genetics, immunology, and virology. It was founded in 1946 and is headquartered in New York City, NY.
36
| Foundation/Endowment | Miscellaneous Commercial Services | 36 |
Public Company | Pharmaceuticals: Major | 17 | |
14
| Subsidiary | Pharmaceuticals: Major | 14 |
Perelman School of Medicine
5
| College/University | Other Consumer Services | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Nancy Simonian tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
AMGEN INC. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal | |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | President Corporate Officer/Principal | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
GILEAD SCIENCES, INC. | Biotechnology | Chief Executive Officer Corporate Officer/Principal Director/Board Member Sales & Marketing Investor Relations Contact | |
IMMUNOGEN, INC. | Biotechnology | Chief Executive Officer Director/Board Member General Counsel | |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
Washington University in St. Louis | College/University | Graduate Degree Undergraduate Degree | |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Director/Board Member Director/Board Member General Counsel Corporate Officer/Principal President | |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Private Equity Investor Private Equity Investor | |
AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Corporate Officer/Principal | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Graduate Degree | |
Stanford University | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
University of Pennsylvania | College/University | Chief Operating Officer Masters Business Admin Masters Business Admin | |
UCB | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
University of Oxford | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
George Washington University | College/University | Doctorate Degree Graduate Degree | |
MACROGENICS, INC. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Investor Relations Contact | |
Boston College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
The University of Chicago | College/University | Doctorate Degree Doctorate Degree Masters Business Admin | |
Yale University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Tufts University | College/University | Undergraduate Degree Undergraduate Degree | |
New York University | College/University | Corporate Officer/Principal Masters Business Admin Masters Business Admin | |
University of California, Irvine | College/University | Corporate Officer/Principal Undergraduate Degree | |
University of Bonn | College/University | Undergraduate Degree Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
The Biotechnology Institute
The Biotechnology Institute Miscellaneous Commercial ServicesCommercial Services The Biotechnology Institute is a non-profit organization, which engages in designing and managing programs about biotechnology research. Its programs include BioGENEius Challenges, leadership awards, and Adopt-A-School. The company was founded in 1998 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
New York Biotechnology Association, Inc.
New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Wallon Institute for Life Lead Sciences | Director/Board Member Director/Board Member | ||
BLUEPRINT MEDICINES CORPORATION | Biotechnology | Chairman Director/Board Member Director of Finance/CFO | |
The Innovative Medicines Initiative
The Innovative Medicines Initiative Drugstore ChainsRetail Trade The Innovative Medicines Initiative is a public-private partnership that aims to accelerate the development of better and safer medicines for patients. The private company is based in Brussels, Belgium and has subsidiaries in Sweden. The Programme Office, led by the Executive Director, manages the day-to-day operations of the initiative. The initiative recognizes the importance of communication and provides accessible tools generated by their projects to help scientists in their research efforts. The Belgian company was founded by J. Kenneth Charles Knowles. | Drugstore Chains | Chairman Director/Board Member | |
Warp Drive Bio, Inc.
Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
Kellogg School of Management | College/University | Graduate Degree Graduate Degree Masters Business Admin | |
The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
VTV THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Dewpoint Therapeutics, Inc.
Dewpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Founder | |
CARGO THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman |
Statistiche
Distribuzione geografica
Stati Uniti | 46 |
Belgio | 4 |
Regno Unito | 2 |
Germania | 2 |
Settori
Health Technology | 27 |
Consumer Services | 18 |
Commercial Services | 4 |
Finance | 3 |
Retail Trade | 2 |
Posizioni
Director/Board Member | 710 |
Corporate Officer/Principal | 240 |
Independent Dir/Board Member | 219 |
Chairman | 157 |
Chief Executive Officer | 138 |
Contatti più connessi
Insiders | |
---|---|
Srini Akkaraju Akkaraju | 54 |
Jonathan Leff | 45 |
Jeffrey Leiden | 43 |
Brian Atwood | 39 |
John Fry | 38 |
John Maraganore | 37 |
Ted Love | 31 |
Steven Holtzman | 28 |
Felix Baker | 28 |
Tim Tyson | 28 |
David Pyott | 27 |
Vaughn M. Kailian | 27 |
James Tobin | 26 |
James Sapirstein | 26 |
Mark Levin | 26 |
- Borsa valori
- Insiders
- Nancy Simonian
- Connessioni Società